CBBB yields 990.10% · PFE yields 6.20%● Live data
📍 CBBB pulled ahead of the other in Year 1
Combined, CBBB + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CBBB + PFE for your $10,000?
Continental Beverage Brands Corporation provides business jet charter services to corporate and private clients. The company offers various aviation services comprising business jet charter management, such as flight scheduling, real-time flight tracking, personal travel coordination, and concierge/helpdesk services; ground transportation management, including transportation scheduling, door-to-door ground transportation coordination, reservation and booking of hotels, meeting facilities and leisure locations, as well as empty leg flights database listing and booking services. It also provides catering management services, including catering concept customization, catering suppliers coordination, aircraft stocking procedure monitoring services; aircraft decoration customization; board and ground security services; and other special services. In addition, the company offers third-party services, such as database management and administrative services for individual and fractional aircraft owners. It was formerly known as Hermes Jets, Inc. and changed its name to Continental Beverage Brands Corporation in February 2015. The company was founded in 2008 and is based in Cornelius, North Carolina. Continental Beverage Brands Corporation is a subsidiary of Raven Investments Plc.
Full CBBB Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.